Cellebrite DI (NASDAQ:CLBT) Stock: Insider David Barter Sells 12,134 Shares

Cellebrite DI Ltd. (NASDAQ:CLBT) CFO David Barter sold 12,134 shares of the firm’s stock in a transaction that occurred on Friday, October 16th. The shares were sold at an average price of $11.21, for a total transaction of $136,022.14. Following the completion of the transaction, the chief financial officer directly owned 322,085 shares of the company’s stock, valued at $3,610,572.85. This represents a 3.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cellebrite DI Stock Up 2.0%

NASDAQ:CLBT opened at $11.37 on Wednesday. The company has a fifty day simple moving average of $11.44 and a two-hundred day simple moving average of $13.06. The company has a market cap of $2.84 billion, a price-to-earnings ratio of 39.80, a price-to-earnings-growth ratio of 1.71 and a beta of 1.14. Cellebrite DI Ltd. has a 52 week low of $9.58 and a 52 week high of $19.98.

Institutional Investors Weigh In On Cellebrite DI

Large investors have recently modified their holdings of the company. Nine Ten Capital Management LLC lifted its position in shares of Cellebrite DI by 19.8% during the 2nd quarter. Nine Ten Capital Management LLC now owns 4,126,808 shares of the company’s stock worth $60,251,000 after purchasing an additional 682,933 shares during the last quarter. Wellington Management Group LLP increased its holdings in Cellebrite DI by 93.7% in the second quarter. Wellington Management Group LLP now owns 3,049,904 shares of the company’s stock valued at $44,529,000 after buying an additional 1,475,579 shares during the last quarter. Renaissance Technologies LLC increased its holdings in Cellebrite DI by 14.7% in the first quarter. Renaissance Technologies LLC now owns 2,860,639 shares of the company’s stock valued at $39,420,000 after buying an additional 365,700 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Cellebrite DI by 33.9% in the first quarter. Principal Financial Group Inc. now owns 2,156,166 shares of the company’s stock valued at $29,712,000 after buying an additional 545,334 shares during the last quarter. Finally, Meitav Investment House Ltd. raised its stake in Cellebrite DI by 34.4% in the first quarter. Meitav Investment House Ltd. now owns 1,954,846 shares of the company’s stock valued at $26,938,000 after buying an additional 500,000 shares in the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. JPMorgan Chase & Co. decreased their target price on Cellebrite DI from $20.00 to $16.00 and set an “overweight” rating for the company in a report on Friday, August 14th. DA Davidson restated a “buy” rating and set a $15.00 price target on shares of Cellebrite DI in a report on Tuesday, September 15th. Weiss Ratings lowered Cellebrite DI from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, August 27th. Needham & Company LLC reduced their price target on Cellebrite DI from $15.00 to $12.50 and set a “buy” rating on the stock in a research report on Friday, August 14th. Finally, Lake Street Capital decreased their price objective on Cellebrite DI from $21.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, August 14th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Cellebrite DI has an average rating of “Moderate Buy” and a consensus price target of $16.70.

Cellebrite DI Company Profile

Cellebrite DI Ltd. (NASDAQ: CLBT) provides digital intelligence and digital forensics solutions that help organizations collect, preserve, analyze and manage data from mobile devices, computers, cloud environments and other digital sources. Its customers include law enforcement agencies, public safety organizations, government and intelligence bodies, military units, and corporate security and investigation teams.

The company’s offerings include tools for accessing and extracting digital evidence, case and evidence management, and investigative analytics.